← Back to Search

Pump Therapy Initiation for Type 1 Diabetes

N/A
Waitlist Available
Led By patricia Olivier, Md
Research Sponsored by St. Justine's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Must not have
Type 1 diabetes diagnosed less than 1 year ago WITH total daily dose of insulin < 0.5U/kg/day
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 days
Awards & highlights

Summary

This trial is testing whether the current pump initiation protocol results in more hypoglycemic episodes than usual.

Who is the study for?
This trial is for children with Type 1 Diabetes who are about to start insulin pump therapy at CHU Sainte-Justine and have an HbA1c level between 7.2 and 9.7%. They must live within 50km of the hospital, have been diagnosed over a year ago unless they use less than 0.5U/kg/day of insulin, and agree to participate.
What is being tested?
The study observes how often kids experience low blood sugar episodes three days before versus three days after starting on an insulin pump, using the current protocol for initiating pump therapy.
What are the potential side effects?
Since this trial involves observation rather than new medication or treatments, there are no direct side effects from interventions being tested; however, risks may include those associated with hypoglycemia.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I was diagnosed with Type 1 diabetes less than a year ago and use less than 0.5 units of insulin per kilogram of my body weight daily.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Congenital Hyperinsulinism
Secondary study objectives
Frequency of hyperglycemias

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients starting pump therapyExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

St. Justine's HospitalLead Sponsor
198 Previous Clinical Trials
84,210 Total Patients Enrolled
patricia Olivier, MdPrincipal InvestigatorSt. Justine's Hospital

Media Library

Observation of hypoglycemias frequency 3 days before and after pump initiation Clinical Trial Eligibility Overview. Trial Name: NCT01840358 — N/A
Type 1 Diabetes Research Study Groups: Patients starting pump therapy
Type 1 Diabetes Clinical Trial 2023: Observation of hypoglycemias frequency 3 days before and after pump initiation Highlights & Side Effects. Trial Name: NCT01840358 — N/A
Observation of hypoglycemias frequency 3 days before and after pump initiation 2023 Treatment Timeline for Medical Study. Trial Name: NCT01840358 — N/A
~2 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top